logo
logo

Allyx Therapeutics, Inc. announced it raised $7.58 Million in an initial filing from an offering of $8.03 Million

Allyx Therapeutics, Inc. announced it raised $7.58 Million in an initial filing from an offering of $8.03 Million

06/02/21, 2:01 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgnew haven
Money raised
$7.58 million
Industry
biotechnology

Company Info

Company
Allyx Therapeutics, Inc.
Location
470 james street
new haven, kentucky, united states
Additional Info
Synapse loss is the main driver of cognition loss in Alzheimer’s patients. Allyx Therapeutics develops products and therapies to reverse neuro-degeneration.

Related People